Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions

QR Code

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions

Antiretroviral therapy (ART) for HIV infection is increasingly being used in resource-poor countries. This has resulted in substantial improvements in the health and life expectancy of HIV patients in these countries, mainly as a result of immune reconstitution. However, the great majority of these...

Full description

Bibliographic Details
Main Authors:	French, M., Price, Patricia
Format:	Journal Article
Published:	2008
Online Access:	http://hdl.handle.net/20.500.11937/48334

Similar Items

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease
by: Tan, D., et al.
Published: (2011)

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy
by: Bundell, C., et al.
Published: (2018)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
by: Price, Patricia, et al.
Published: (2009)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
by: Tan, D., et al.
Published: (2009)

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy
by: Hearps, A., et al.
Published: (2016)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
by: Goh, Kian Guan, et al.
Published: (2017)

Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
by: Wulandari, E., et al.
Published: (2017)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
by: Brunt, S., et al.
Published: (2016)

The role of human herpesvirus (HHV) infections and persistent immune activation in antiretroviral therapy-treated HIV infected individuals / Yap Siew Hwei
by: Yap, Siew Hwei
Published: (2018)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

Immunological determinants of tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in HIV-infected patients on antiretroviral therapy / Tan Hong Yien
by: Tan, Hong Yien
Published: (2016)

Immune restoration diseases reflect diverse immunopathological mechanisms
by: Price, Patricia, et al.
Published: (2009)

Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia
by: Sumatoh, H., et al.
Published: (2011)

Ethnicity as predictor of immune reconstitution among Malaysian HIV‐positive patients treated with highly active antiretroviral therapy
by: Mohamad Isa, Irma Izani, et al.
Published: (2020)

Mycobacterial immune restoration disease: One symphony, two or many?
by: Price, Patricia
Published: (2012)

Polymorphisms in IL10 may alter CD4 T-cell counts in Indonesian HIV patients beginning antiretroviral therapy
by: Dmello, D., et al.
Published: (2017)

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation
by: Agarwal, U., et al.
Published: (2012)

Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
by: Hejazi, Nazisa, et al.
Published: (2010)

CD4 + T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4 + T cells
by: Fernandez, S., et al.
Published: (2011)

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease
by: Lim, A., et al.
Published: (2008)

Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia
by: Hejazi, Nazisa, et al.
Published: (2014)

Nadir CD4 T-cell counts continue to influence interferon-? responses in HIV patients who began antiretroviral treatment with advanced immunodeficiency
by: Price, Patricia, et al.
Published: (2008)

Increased plasma CXCL10 may be a marker of increased risk of immune restoration disease associated with nonviral pathogens
by: Oliver, B., et al.
Published: (2012)

Predictors of adherence behaviour among HIV positive patients receiving Antiretroviral Therapy (ART) in Malaysia
by: Abdulrahman, Surajudeen Abiola, et al.
Published: (2015)

Immunopathogenesis of hepatic flare in HIV/hepatitis b virus (Hbv)-coinfected individuals after the initiation of Hbv-active antiretroviral therapy
by: Crane, M., et al.
Published: (2009)

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis
by: Tan, D., et al.
Published: (2008)

Socioeconomic predictors of adherence behavior among HIV-positive patients receiving antiretroviral therapy in Selangor, Malaysia
by: Abdulrahman, Surajudeen Abiola, et al.
Published: (2017)